Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy-Reference-Cited by-同舟云学术

Myasthenia Gravis Complicated with Peripheral T-cell Lymphoma, Not Otherwise Specified (PTCL-NOS), Following Thymectomy and Longstanding Tacrolimus Therapy

Published:2018 Issue:4 Volume:57 Page:601-604
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Ohara Masahiro¹,Ozaki Kokoro¹,Ohkubo Takuya¹,Yamada Akane¹,Numasawa Yoshiyuki¹,Tanaka Keisuke²,Tomii Shohei³,Ishibashi Satoru¹,Sanjo Nobuo¹,Yokota Takanori¹

Affiliation:

1. Department of Neurology and Neurological Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan

2. Department of Hematology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan

3. Department of Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/4/57_9167-17/_pdf

Reference29 articles.

1. 1. Romi F, Gilhus NE, Aarli JA. Myasthenia gravis: clinical, immunological and therapeutic advances. Acta Neurol Scand 111: 134-141, 2005.

2. 2. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Ed. Steven H, Swerdlow EC, Harris NL, et al., Eds. International Agency for Research on Cancer, Lyon, France, 2008.

3. 3. Cory RF, Rios C, Kaya K, et al. Composite lymphocyte-rich thymoma and peripheral T-cell lymphoma not otherwise specified: case report and literature review. Lab Med 43: 4-8, 2012.

4. 4. Azzi JR, Sayegh MH, Mallat SG. Calcineurin inhibitor: 40 years later, can't live without... J Immunol 191: 5785-5791, 2013.

5. 5. Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS): Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71: 1065-1068, 2001.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer in myasthenia gravis subtypes in relation to immunosuppressive treatment and acetylcholine receptor antibodies: A Swedish nationwide register study;European Journal of Neurology;2021-01-28

2. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders, Diffuse Large B-Cell Lymphoma Type, in a Patient with Behçet’s Disease Treated with Cyclosporine A;Case Reports in Oncology;2020-09-21

3. Neonatal thymectomy in children—accelerating the immunologic clock?;Journal of Allergy and Clinical Immunology;2020-08

4. Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare association;Leukemia Research Reports;2020

5. Mucosa-associated lymphoid tissue lymphoma of the accessory parotid gland presenting as a simple cheek mass;Medicine;2019-09